Cancer Patients With Breakthrough COVID-19 Remain at Risk for Severe Outcomes
No significant difference observed in 30-day mortality for fully vaccinated versus unvaccinated cancer patients with COVID-19
NVX-CoV2373 Vaccine Protects Against COVID-19
Study conducted in the U.S. and Mexico shows vaccine 90 percent effective overall, 100 percent effective against moderate-to-severe disease
Omicron Cases Pass U.S. Peak Seen With Delta
However, numbers of hospitalizations have not yet reached those higher levels
Efficacy of Bamlanivimab for COVID-19 May Vary With Antibody Status
Further study needed to determine whether bamlanivimab could benefit patients who are negative for endogenous neutralizing antibodies
Physician’s Briefing Weekly Coronavirus Roundup
Omicron Now Accounts for 73 Percent of New COVID-19 Cases
Rate suggests there were more than 650,000 omicron infections in the United States last week
2019 to 2020 Saw 16.8 Percent Increase in U.S. Death Rate
Age-specific death rates increased for each age group 15 years and older; COVID-19 became third leading cause of death in 2020
Biden Outlines Measures to Fight Omicron, Pleads With Americans to Get Vaccinated
Included in the battle plan announced Tuesday are measures to distribute 500 million free rapid COVID-19 tests to the public
Factors ID’d for Severe GI Effects of SARS-CoV-2 in Children
Among children infected with SARS-CoV-2, 9.5 percent have severe GI effects, such as disseminated adenomesenteritis, appendicitis, pancreatitis
Biden to Address Nation Tuesday on Omicron Response, Outlook
President expected to detail how the government will respond to rising case levels, and to urge Americans to get vaccinated
